NeuroSense Therapeutics Ltd. Additions To Rightofuse Assets
NeuroSense Therapeutics Ltd. (NRSN) reported Additions To Rightofuse Assets of $306.00 thousand for the 12-month period ending 2022-12-31, per its 20-F filed 2023-03-22.
Discontinued › Notes
ifrs-full:AdditionsToRightofuseAssets · last filed 2023-03-22
| Period end | Additions To Rightofuse Assets 6 month | Additions To Rightofuse Assets 12 month |
|---|---|---|
| 2022-12-31 | $306.00K 20-F · filed 2023-03-22 | |
| 2022-06-30 | $306.00K 6-K/A · filed 2023-01-19 |